跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 116,241 条关于
“PNPLA3 I148M liver disease”
全部
116,241
临床试验
92,090
药物
1,827
机构
209
资讯
22,115
11个月前
Wave Life Sciences Reports Dose-Dependent Activin E Reductions Up to 85% with WVE-007 in Obesity Trial
4天前
Wave Life Sciences Begins Phase 2a Trial of INHBE siRNA WVE-007 Combined With Tirzepatide in Obesity
去年
Evolving Landscape of MASLD: New Insights and Therapeutic Approaches
8个月前
ProQR Reports Positive Phase 1 Safety Data for RNA Editing Therapy AX-0810, Advances Pipeline Programs
去年
Wave Life Sciences Advances Obesity and Cardiometabolic Programs with RNA Therapies
4个月前
Roche Launches Comprehensive Liver Disease Panel to Transform Chronic Liver Disease Management
去年
NASH Pipeline Shows Promise with 80+ Emerging Therapies in Development
去年
GSK Acquires Efimosfermin for $1.2 Billion to Target Steatotic Liver Disease
去年
Mirum Pharmaceuticals Advances in Liver Disease Treatments
5年前
Rising Liver Cancer Cases in the US Linked to Alcohol-Associated Liver Disease and MASLD
第 1 页，共 2212 页
上一页
下一页
